Read Our Latest Issue A method for designing novel compounds could help defeat drug-resistant bacteria It's hard to imagine a world without antibiotics, but because of widespread overuse of the drugs, that's where we're headed. The Centers for Disease Control and Prevention says that in the U.S. alone, more than 23,000 people now die every year from infections that antibiotics can no longer cure. A study commissioned by the U.K. government estimated that by 2050, antibiotic resistance will cause 10 million deaths worldwide annually. Scientists have struggled to develop new drugs that can kill these superbugs. Consider the major class of antibiotics called macrolides, which treat common bacterial infections, including pneumonia, strep throat, ear and skin infections, and sexually transmitted diseases. This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.